Clinical Trials Browser

Withdrawn × toripalimab × Clear all

NCT03623776 2024-12-06

NAJSCR

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT06105008 2024-08-23

Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT05650203 2023-04-05

A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

Phase 1 Withdrawn

Primary Condition: Advanced Tumors

NCT05212922 2023-03-20

YH001

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT05253105 2022-05-31

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

Phase 1 Withdrawn

Neoplasms

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT03919383 2019-06-03

Phase II of Lenvatinib Plus Toripalimab for Advanced HCC

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular